<p>John Abrams of the University of Texas Southwestern Medical Center in the U.S. will utilize novel mutagenesis and selection strategies to develop new variants of the Cry protein, a toxin producing the pathogen Bt, in an effort to create customized insecticides that can selectively target disease vectors without harming humans and non-target species.</p>


John Abrams of the University of Texas Southwestern Medical Center in the U.S. will utilize novel mutagenesis and selection strategies to develop new variants of the Cry protein, a toxin producing the pathogen Bt, in an effort to create customized insecticides that can selectively target disease vectors without harming humans and non-target species.

Customized Insecticides for Combating Disease Vectors

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.